Mitroja 7.5 Tablet
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Mirtazapine (7.5mg)
Overview Mitroja 7.5 Tablet
Deprexis 7.5mg tablets are indicated for managing depressive disorders. This medication elevates brain levels of serotonin and norepinephrine, neurotransmitters that promote calmness and nerve relaxation, thereby alleviating depressive symptoms. Deprexis 7.5mg can be administered with or without food; consistent daily dosing ensures stable blood levels. Missed doses should be taken as soon as recalled; complete the prescribed course, even with symptom improvement, and avoid abruptly discontinuing treatment to prevent symptom exacerbation. Commonly reported side effects include xerostomia, increased hunger, and cephalalgia. Drowsiness and vertigo may occur; avoid activities requiring alertness until the medication's effects are understood. Weight gain is possible; maintain a healthy diet and exercise routine. Report any fever or pharyngitis to your physician immediately.
Uses of Mitroja 7.5 Tablet
Managing Depressive Disorders
Major Benefits of Mitroja 7.5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mitroja 7.5 Tablet whole; do not break, crush, or chew it. Consumption with or without food is acceptable, however, consistent timing is recommended.
Common Side effects of Mitroja 7.5 Tablet:
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mitroja 7.5 Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mitroja 7.5 Tablet can be consumed with or without food, although consistent daily timing is recommended.
How Mitroja 7.5 Tablet works:
Mitroja 7.5mg tablets are prescribed for depression. Their mechanism of action involves elevating serotonin and noradrenaline, neurotransmitters crucial for healthy brain function and emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mitroja 7.5 Tablet and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Use of Mitroja 7.5 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Mitroja 7.5 Tablet while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer to breast milk, posing a risk to the infant. Close observation of the infant for developmental delays and growth issues is recommended.
DrivingUNSAFE
Driving may be affected by Mitroja 7.5 Tablet side effects, which can reduce concentration and alertness. This medication may compromise your ability to drive safely.
KidneyCAUTION
Patients with kidney impairment should use Mitroja 7.5 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Mitroja 7.5mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised.
What if you forget to take Mitroja 7.5 Tablet :
Should you forget a Mitroja 7.5 Tablet dose, take it promptly. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Mitroja 7.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Tetracyclic Piperazinoazepine |
| Developing Habits | No. |
| Treatment Category | Neuroscience |
| Actions | Norepinephrine and serotonin-specific antidepressants (NaSSAs) |
3,018 People bought this recently